Aktis Oncology AKTS
NASDAQ AKTS
$16.62 +0.34 (+2.09%)
At close: Nov 13, 2026 · 4:00 PM EST

Aktis Oncology (AKTS) Research & Development (2025 - 2026)

Updated

Aktis Oncology's Research & Development came in at $32.13 million for Q3 2026, up 95.1% from $16.47 million a year earlier and up 27.1% from the prior quarter.

Analysis

Aktis Oncology (AKTS) Research & Development (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Aktis Oncology reported Research & Development of $93.93 million; for FY2025, it came in at $67.45 million, up 64.7% from FY2024.

  • Going back by year, Research & Development was $40.95 million in FY2024.
  • Year-over-year, Research & Development has increased for three consecutive quarters.
  • Business Quant data shows AKTS's Research & Development at $25.28 million (Q2 2026), $20.04 million (Q1 2026) and $16.49 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 4.25 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 4.65 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 2.57 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 4.54 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 3.89 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 2.11 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 1.61 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 3.02 Bn
10 Aktis Oncology 895.95 Mn 335.72 Mn - 32.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 32.13 Mn
Jun 30, 2026 25.28 Mn
Mar 31, 2026 20.04 Mn
Jun 30, 2025 18.63 Mn
Mar 31, 2025 15.86 Mn
API Access

Aktis Oncology Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=AKTS&period=max&api_key=YOUR_API_KEY